A CD46-binding chimpanzee adenovirus vector as a vaccine carrier. (Q40182476)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

A CD46-binding chimpanzee adenovirus vector as a vaccine carrier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Nia Tatsis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ariella Blejer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Marcio O Lasaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Scott E Hensley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ann Cun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Lello Tesema

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Yan Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Guang-Ping Gao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Zhi Q Xiang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Dongming Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Hildegund C J Ertl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

16 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

608-617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17228314%20AND%20SRC:MED&resulttype=core&format=json

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Replication-defective vector based on a chimpanzee adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

CD46 is a cellular receptor for group B adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Mapping of the primary binding site of measles virus to its receptor CD46.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

CD46 is a cellular receptor for human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Human adenovirus type 35: nucleotide sequence and vector development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021

Generation of an adenoviral vaccine vector based on simian adenovirus 21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300078

7 January 2021